BioSpace

Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026

ObesityWeek 2026, which kicks off on Saturday, will spotlight presentations on the ascendant amylin pathway, as well as therapies looking to improve the quality of weight loss and patients’ persistence on treatment.

By BioSpace

1 min read
Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights